The purpose of this study is to describe common treatment pathways, to collect health care utilization data and to assess symptom load as well as impact of symptoms on daily life in GERD patients who are partial-responders to PPI treatment.

Inclusion Criteria:

• At least 6 month history of GERD symptoms
• Treated with unchanged optimized PPI treatment for any GERD indication during a consecutive 4 week period
• Remaining GERD symptoms despite optimized PPI treatment
• Able to read and write in US English, and able to comply with study requirements

Exclusion Criteria:

• Patients that have not experienced any GERD symptom improvement at all during PPI treatment
• Involvement in the planning or conduct of the study
• Involvement in any other observational study or in any clinical study at the time of this study or during the last 6 months

Patients with Gastroesophageal Reflux Disease (GERD) classified as partial responders to proton pump inhibitors (PPIs).